4.6 Article

Integrated analysis of the roles of oxidative stress related genes and prognostic value in clear cell renal cell carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade

Bufu Tang et al.

Summary: This study validates the significant role of xCT in the tumorigenesis and stemness of colorectal cancer (CRC), and identifies the upstream transcription factor and co-expressed protein associated with xCT. The study suggests that controlling the activation of relevant signaling pathways through xCT knockdown and specific inhibitors can effectively inhibit tumor progression in CRC.

CELL DEATH & DISEASE (2022)

Review Cell Biology

The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy

Yongchang Lai et al.

Summary: Renal cell carcinoma (RCC) is a common urinary system tumor, with clear cell renal cell carcinoma being the most prevalent subtype. Advanced RCC is treated with molecular-targeted drugs and immune checkpoint inhibitors, but resistance may occur due to the dynamic tumor microenvironment and metabolic characteristics. Novel findings on the TME and tumor metabolism in RCC may offer insights for future treatment strategies to overcome resistance.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Biochemistry & Molecular Biology

Prolyl Hydroxylase 3 Knockdown Accelerates VHL-Mutant Kidney Cancer Growth In Vivo

Niki M. Zacharias et al.

Summary: The study showed that the expression levels of PHD3 in ccRCC cells can affect the expression of HIF2α, tumor growth, and cell proliferation under oxidative stress conditions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

The Association of Polymorphisms in Nrf2 and Genes Involved in Redox Homeostasis in the Development and Progression of Clear Cell Renal Cell Carcinoma

Smiljana Mihailovic et al.

Summary: Research suggests that SNPs found in specific genes may modify the risk for clear cell renal cell carcinoma (ccRCC) development and progression, with variant forms of GSTP1 potentially affecting overall survival in ccRCC patients.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Article Immunology

Transcriptional Profiling Reveals Kidney Neutrophil Heterogeneity in Both Healthy People and ccRCC Patients

Yiliang Meng et al.

Summary: This study utilized single-cell RNA sequencing to explore the subpopulation distribution of neutrophils in a healthy kidney and ccRCC, revealing different functional characteristics in these two environments. Neutrophils in ccRCC may exhibit resistance to immune therapies, suggesting potential challenges in using these treatments for this type of renal cancer.

JOURNAL OF IMMUNOLOGY RESEARCH (2021)

Article Biochemistry & Molecular Biology

Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence

Geraldine Luis et al.

Summary: The study revealed that SCD1 and FABP4 play essential roles in tumor recurrence by enhancing antioxidant and anti-ferroptotic resources. Inhibiting lipid transport and targeting SCD1 can effectively reduce tumor regrowth.

REDOX BIOLOGY (2021)

Article Reproductive Biology

Knockdown of PYCR1 suppressed the malignant phenotype of human hepatocellular carcinoma cells via inhibiting the AKT pathway activation

Jiang Guo et al.

Summary: The study demonstrated that high expression of PYCR1 in hepatocellular carcinoma leads to poor prognosis, while silencing PYCR1 inhibits proliferation, invasion, and migration of HCC cells and promotes apoptosis and G1 arrest. This suggests that targeting PYCR1 could be a potential therapeutic strategy for human HCC.

REPRODUCTIVE BIOLOGY (2021)

Review Medicine, Research & Experimental

Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages

Degao Chen et al.

Summary: The article discusses the metabolic regulation between TME and TAMs. Immune molecules from TAMs and TME act as mediators of signal transduction. TAMs are influenced by metabolites produced in the TME.

THERANOSTICS (2021)

Review Urology & Nephrology

Potential New Therapeutic Approaches for Renal Cell Carcinoma

David C. Yang et al.

SEMINARS IN NEPHROLOGY (2020)

Article Multidisciplinary Sciences

Mutational signatures in tumours induced by high and low energy radiation in Trp53 deficient mice

Yun Rose Li et al.

NATURE COMMUNICATIONS (2020)

Review Oncology

Oxidative Stress in Cancer

John D. Hayes et al.

CANCER CELL (2020)

Review Pharmacology & Pharmacy

MELK/MPK38 in cancer: from mechanistic aspects to therapeutic strategies

Karthik Thangaraj et al.

DRUG DISCOVERY TODAY (2020)

Article Medicine, Research & Experimental

PYCR1 promotes the progression of non-small-cell lung cancer under the negative regulation of miR-488

Dongchang Wang et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Biochemistry & Molecular Biology

Redox-Mediated Mechanism of Chemoresistance in Cancer Cells

Eun-Kyung Kim et al.

ANTIOXIDANTS (2019)

Article Oncology

Cancer Statistics, 2018

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Article Oncology

Adipocytes Sequester and Metabolize the Chemotherapeutic Daunorubicin

Xia Sheng et al.

MOLECULAR CANCER RESEARCH (2017)

Article Medicine, General & Internal

Renal cell carcinoma

James J. Hsieh et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Article Oncology

Cancer Statistics, 2017

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

Article Multidisciplinary Sciences

Stratification and therapeutic potential of PML in metastatic breast cancer

Natalia Martin-Martin et al.

NATURE COMMUNICATIONS (2016)

Review Endocrinology & Metabolism

Proline metabolism and cancer: emerging links to glutamine and collagen

James M. Phang et al.

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2015)

Review Oncology

Mitochondrial reactive oxygen species and cancer

Lucas B. Sullivan et al.

CANCER & METABOLISM (2014)

Review Cell Biology

Oxidative stress and cancer: An overview

Venus Sosa et al.

AGEING RESEARCH REVIEWS (2013)

Article Biochemistry & Molecular Biology

Thioredoxin inhibits MPK38-induced ASK1, TGF-β, and p53 function in a phosphorylation-dependent manner

Ravi Manoharan et al.

FREE RADICAL BIOLOGY AND MEDICINE (2013)

Review Oncology

Current and future systemic treatments for renal cell carcinoma

Rosalie Fisher et al.

SEMINARS IN CANCER BIOLOGY (2013)

Article Biochemistry & Molecular Biology

Murine Protein Serine-threonine Kinase 38 Activates p53 Function through Ser15 Phosphorylation

Hyun-A Seong et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Urology & Nephrology

Status of Oxidative Stress in Patients With Renal Cell Carcinoma

Raguram Ganesamoni et al.

JOURNAL OF UROLOGY (2012)

Review Urology & Nephrology

ICUD-EAU International Consultation on Kidney Cancer 2010: Treatment of Metastatic Disease

Jean-Jacques Patard et al.

EUROPEAN UROLOGY (2011)

Article Urology & Nephrology

The genetic basis of kidney cancer: a metabolic disease

W. Marston Linehan et al.

NATURE REVIEWS UROLOGY (2010)

Review Biotechnology & Applied Microbiology

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Dunyaporn Trachootham et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Article Biochemistry & Molecular Biology

Murine Protein Serine/Threonine Kinase 38 Activates Apoptosis Signal-regulating Kinase 1 via Thr838 Phosphorylation

Haiyoung Jung et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Oncology

Loss of promyelocytic leukemia protein in human gastric cancers

Hee Eun Lee et al.

CANCER LETTERS (2007)

Review Pharmacology & Pharmacy

ROS stress in cancer cells and therapeutic implications

H Pelicano et al.

DRUG RESISTANCE UPDATES (2004)